Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of bOPV and IPV Sequential Schedules in Infants
NCT03614702Phase 3Completed
- Sponsor
- Institute of Medical Biology
- Start
- Sep 2015
- Primary completion
- Aug 2016
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of bivalent oral poliovirus vaccine in poliomyelitis, sponsored by Institute of Medical Biology. Started Sep 2015; status: completed.
02
Drugs
bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03614702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03614702.